Pioneering Study in Parkinson's Disease to Advance Surgical Treatment Options RebrAIn, a leader in precise targeting solutions for deep brain stimulation (DBS) and lesion techniques, today announced ...

RebrAIn, specialized in precise targeting solutions for DBS treatments and lesion techniques, completed the recruitment of ...

TORONTO, ON, Oct. 1, 2024 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech and medical device industries. Access to all ...

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whether to participate in cancer trials, according to surveys of patients ...

After a six-month beta testing period, the European Clinical Trials Information Network is rolling out its patient ...

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about ...

Clinical trial recruitment stands at the forefront of drug and medical device development for companies, yet it often ...

ImPact Biotech shared interim results at the American Society of Clinical Oncology 2024 in June in which 10 of the 13 (77%) response-evaluable patients achieved a CR at the end of ITP. The company is ...

Patient recruitment stands as a critical component in the success of clinical trials. Without enough participants, trials ...

DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial In Q3 2024, DBV exceeded its recruitment goal and successfully closed the screening process for the VITESSE Phase 3 study ...

A new report from the American Hospital Association using data analyzed by Vizient finds that hospital performance on key patient safety and quality measures is better in the first quarter of 2024 ...

ImageBloom, Inc. a leader in clinical trial support solutions, is excited to announce the launch of the Patient Recruitment Marketplace, the first-of- ...